Psychemedics Corp. Sets 2024 Annual Meeting Date
Ticker: PMDI · Form: DEF 14A · Filed: Oct 18, 2024 · CIK: 806517
| Field | Detail |
|---|---|
| Company | Psychemedics Corp (PMDI) |
| Form Type | DEF 14A |
| Filed Date | Oct 18, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $2.35, $3,750,000, $15,000, $0.005 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Psychemedics 2024 annual meeting is Nov 25. Proxy filed Oct 18.
AI Summary
Psychemedics Corporation is holding its 2024 Annual Meeting of Stockholders on November 25, 2024. The definitive proxy statement was filed on October 18, 2024, and details the matters to be discussed at the meeting. The company is based in Acton, MA, and operates in the medical laboratories sector.
Why It Matters
This filing informs shareholders about the upcoming annual meeting, outlining the agenda and their rights to vote on corporate matters, which is crucial for corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual shareholder meeting and does not contain significant new financial or strategic information.
Key Numbers
- 2024 — Annual Meeting Year (The filing pertains to the 2024 Annual Meeting of Stockholders.)
Key Players & Entities
- PSYCHEMEDICS CORP (company) — Registrant
- October 18, 2024 (date) — Filing Date
- November 25, 2024 (date) — Annual Meeting Date
- Acton, MA (location) — Company Headquarters
FAQ
When is the 2024 Annual Meeting of Stockholders for Psychemedics Corporation?
The 2024 Annual Meeting of Stockholders is scheduled for November 25, 2024.
What is the filing date of this Definitive Proxy Statement?
The Definitive Proxy Statement was filed on October 18, 2024.
Where is Psychemedics Corporation headquartered?
Psychemedics Corporation is located at 125 Nagog Park, Acton, MA 01720.
What is the Standard Industrial Classification code for Psychemedics Corporation?
The Standard Industrial Classification code for Psychemedics Corporation is 8071, which falls under SERVICES-MEDICAL LABORATORIES.
Under which section of the SEC regulations is this document filed?
This document is filed as a Schedule 14A Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934.
Filing Stats: 4,607 words · 18 min read · ~15 pages · Grade level 14.9 · Accepted 2024-10-18 11:50:17
Key Financial Figures
- $2.35 — or his designee at a purchase price of $2.35 per share, for an aggregate purchase pr
- $3,750,000 — or an aggregate purchase price of up to $3,750,000 (the “Stock Purchase Agreement,&r
- $15,000 — n of proxies for a fee of approximately $15,000, plus reimbursement of related expenses
- $0.005 — e 5,894,461 shares of our common stock, $0.005 par value (the “common stock&rdqu
Filing Documents
- def14a_101824.htm (DEF 14A) — 1470KB
- logo.jpg (GRAPHIC) — 29KB
- miruslogo.jpg (GRAPHIC) — 2KB
- mirus_sign.jpg (GRAPHIC) — 3KB
- hullinger.jpg (GRAPHIC) — 7KB
- proxy_01.jpg (GRAPHIC) — 94KB
- proxy_02.jpg (GRAPHIC) — 93KB
- 0001171843-24-005690.txt ( ) — 1785KB
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS 80 PROPOSAL 1 ELECTION OF DIRECTORS 82 EXECUTIVE OFFICERS 83
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 84 Overview of Compensation Program 84 Compensation Philosophy and Objectives 84 Role of Executive Officers in Compensation Decisions 84 Setting Executive Compensation 84 2023 Executive Compensation Components 85 Tax and Accounting Implications 86 Summary of Cash and Certain Other Compensation 86 Employment Contracts 87 Potential Payments upon Termination and Change in Control 89 Equity Compensation Plan Information 89 Pay Versus Performance 89 iv PRINCIPAL STOCKHOLDERS AND STOCKHOLDINGS OF MANAGEMENT 92 PROPOSAL 2 ADVISORY VOTE ON EXECUTIVE COMPENSATION 94 PROPOSAL 3 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 96 PROPOSAL 4 AMENDMENTS TO THE COMPANY’S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT 97 PROPOSAL 5 AMENDMENT TO THE COMPANY’S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO EFFECT A FORWARD STOCK SPLIT 99 PROPOSAL 6 RATIFICATION OF THE TERMS AND CONDITIONS OF THE STOCK PURCHASE AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THE STOCK PURCHASE AGREEMENT 100 PROPOSAL 7 APPROVAL OF THE ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY OR APPROPRIATE, INCLUDING TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE ANNUAL MEETING TO APPROVE ANY PROPOSAL OR TO ESTABLISH QUORUM 103 INFORMATION ABOUT THE COMPANY 104 Market Price of Common Stock 104 Dividends 104 Stockholders 105 The Filing Persons 105 Stock Purchases by Filing Persons 105 v Directors and Executive Officers 105 OTHER MATTERS 106 Voting Procedures 106 Other Proposed Action 106 Stockholder Communications 106 Stockholder Proposals and Nominations for Director 106 Delinquent Section 16(a) Reports 107 Can I Change My Vote After I Have Voted? 108 Incorporation By Reference 108 Annual Report on Form 10-K 108 FINANCIAL INFORMATION 109 Summary Historical Financial